首页|Effectiveness of mRNA COVID-19 Vaccines in Japan during the Nationwide Pandemic of the Delta Variant

Effectiveness of mRNA COVID-19 Vaccines in Japan during the Nationwide Pandemic of the Delta Variant

扫码查看
原文链接
  • NSTL
  • Tohoku Univ Medical Press
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remained a major global health concern in 2021. To suppress the spread of infection, mass vaccinations have been performed across countries worldwide. In Japan, vaccinations of the first and second doses for most of the nation were performed during the nationwide outbreak of the B.1.617.2 (Delta) variant with the L452R spike protein mutation, and the effectiveness of the vaccinations to suppress the spread of COVID-19 among the people in Japan remains uncertain. In this study, adults aged >= 18 years, who were in contact with patients with COVID-19 and underwent nasopharyngeal swab reverse transcription-polymerase chain reaction (RT-PCR) tests during August and September 2021 at a mass screening test center in Japan, were enrolled. In this period, more than 95% of the COVID-19 infections were reportedly caused by the Delta variant. As a result, a total of 784 adults with recent contact history, including 231 (29.5%) RT-PCR test-positive cases, were enrolled. The test positivity rate was lower in individuals who had been vaccinated twice than in unvaccinated individuals (12.5% vs. 39.0%, p < 0.0001), with the risk ratio of 0.32 (95% confidence interval 0.23-0.46). The vaccine effectiveness was the highest between 7-90 days after the second vaccine dose. In conclusion, two doses of mRNA COVID-19 vaccines effectively suppressed transmission in Japan during the nationwide pandemic of the Delta variant, estimated to have prevented 50-80% of the infection.

coronavirus disease 2019 (COVID-19)Delta variantL452R spike protein mutationmRNA vaccinessevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Akaishi, Tetsuya、Kushimoto, Shigeki、Katori, Yukio、Sugawara, Noriko、Igarashi, Kaoru、Fujita, Motoo、Kure, Shigeo、Takayama, Shin、Abe, Michiaki、Kikuchi, Akiko、Ishizawa, Kota、Abe, Yoshiko、Imai, Hiroyuki、Inaba, Yohei、Iwamatsu-Kobayashi, Yoko、Nishioka, Takashi、Onodera, Ko、Ishii, Tadashi

展开 >

Dept Educ & Support Reg Med,Tohoku Univ Hosp

Div Emergency & Crit Care Med,Tohoku Univ

Dept Otolaryngol Head & Neck Surg,Tohoku Univ

Dept Pediat,Tohoku Univ

Div Craniofacial Anomalies,Tohoku Univ

Dept Emergency & Crit Care Med,Tohoku Univ Hosp

Clin Skills Lab,Tohoku Univ

Int Res Inst Disaster Sci,Tohoku Univ

Dept Dent Infect Control,Tohoku Univ Hosp

Liaison Ctr Innovat Dent,Tohoku Univ

展开 >

2022

10.1620/tjem.2022.J012

The Tohoku Journal of Experimental Medicine

The Tohoku Journal of Experimental Medicine

ISSN：0040-8727
年,卷(期)：2022.257(1)
  • 1
  • 12